Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

NEJM 3/19- part of the fun of getting the New England Journal of Medicine is that you get the online version the day before it comes out A glimpse of the future.

This is prob the most widely read journal for MD's worldwide, published right here in Waltham MA.

Tomorrow's edition includes 3-count 'em 3-articles about skin infections. One is even about Gm + drugs, and antimicrobial resistance, and is focused on Teixobactin. ( Brilacidin not mentioned ) .Teixobactin gets a lot of press and "no resistance "(known so far) also played up. Part of its appeal is its activity against tuberculosis(M. Tb) Will try to summarize when not beat.